Skip to Main Content

Paper Details

Pevonedistat (MLN4924), a First-in-Class NEDD8-activating enzyme inhibitor, in patients with acute myeloid leukaemia and myelodysplastic syndromes: a phase 1 study.
Br J Haematol
186
2015
Author NameAffiliation
Ronan SwordsSylvester Comprehensive Cancer Center
  • 1 - 1

Datasets

Release 1.2